144 related articles for article (PubMed ID: 12880383)
21. Toxins of Bacillus anthracis.
Brossier F; Mock M
Toxicon; 2001 Nov; 39(11):1747-55. PubMed ID: 11595637
[TBL] [Abstract][Full Text] [Related]
22. Role of furin in delivery of a CTL epitope of an anthrax toxin-fusion protein.
Zhang Y; Kida Y; Kuwano K; Misumi Y; Ikehara Y; Arai S
Microbiol Immunol; 2001; 45(2):119-25. PubMed ID: 11293477
[TBL] [Abstract][Full Text] [Related]
23. Anthrax lethal factor cleaves the N-terminus of MAPKKs and induces tyrosine/threonine phosphorylation of MAPKs in cultured macrophages.
Vitale G; Pellizzari R; Recchi C; Napolitani G; Mock M; Montecucco C
Biochem Biophys Res Commun; 1998 Jul; 248(3):706-11. PubMed ID: 9703991
[TBL] [Abstract][Full Text] [Related]
24. Anthrax toxin lethal factor domain 3 is highly mobile and responsive to ligand binding.
Maize KM; Kurbanov EK; De La Mora-Rey T; Geders TW; Hwang DJ; Walters MA; Johnson RL; Amin EA; Finzel BC
Acta Crystallogr D Biol Crystallogr; 2014 Nov; 70(Pt 11):2813-22. PubMed ID: 25372673
[TBL] [Abstract][Full Text] [Related]
25. Matrix metalloproteinase-activated anthrax lethal toxin demonstrates high potency in targeting tumor vasculature.
Liu S; Wang H; Currie BM; Molinolo A; Leung HJ; Moayeri M; Basile JR; Alfano RW; Gutkind JS; Frankel AE; Bugge TH; Leppla SH
J Biol Chem; 2008 Jan; 283(1):529-540. PubMed ID: 17974567
[TBL] [Abstract][Full Text] [Related]
26. Anthrax fusion protein therapy of cancer.
Frankel AE; Powell BL; Duesbery NS; Vande Woude GF; Leppla SH
Curr Protein Pept Sci; 2002 Aug; 3(4):399-407. PubMed ID: 12370003
[TBL] [Abstract][Full Text] [Related]
27. Manipulation of host signalling pathways by anthrax toxins.
Turk BE
Biochem J; 2007 Mar; 402(3):405-17. PubMed ID: 17313374
[TBL] [Abstract][Full Text] [Related]
28. Anthrax toxin.
Collier RJ; Young JA
Annu Rev Cell Dev Biol; 2003; 19():45-70. PubMed ID: 14570563
[TBL] [Abstract][Full Text] [Related]
29. Novel protein targeted therapy of metastatic melanoma.
Frankel AE; Koo HM; Leppla SH; Duesbery NS; Vande Woude GF
Curr Pharm Des; 2003; 9(25):2060-6. PubMed ID: 14552326
[TBL] [Abstract][Full Text] [Related]
30. Purification and biophysical characterization of the core protease domain of anthrax lethal factor.
Gkazonis PV; Dalkas GA; Chasapis CT; Vlamis-Gardikas A; Bentrop D; Spyroulias GA
Biochem Biophys Res Commun; 2010 Jun; 396(3):643-7. PubMed ID: 20438702
[TBL] [Abstract][Full Text] [Related]
31. Inhibition of mitogen-activated protein kinase signalling by Bacillus anthracis lethal toxin causes destabilization of interleukin-8 mRNA.
Batty S; Chow EM; Kassam A; Der SD; Mogridge J
Cell Microbiol; 2006 Jan; 8(1):130-8. PubMed ID: 16367872
[TBL] [Abstract][Full Text] [Related]
32. Self-association of the transmembrane domain of an anthrax toxin receptor.
Go MY; Kim S; Partridge AW; Melnyk RA; Rath A; Deber CM; Mogridge J
J Mol Biol; 2006 Jun; 360(1):145-56. PubMed ID: 16756998
[TBL] [Abstract][Full Text] [Related]
33. Antitumor efficacy of a urokinase activation-dependent anthrax toxin.
Rønø B; Rømer J; Liu S; Bugge TH; Leppla SH; Kristjansen PE
Mol Cancer Ther; 2006 Jan; 5(1):89-96. PubMed ID: 16432166
[TBL] [Abstract][Full Text] [Related]
34. Metalloproteinase inhibitors, nonantimicrobial chemically modified tetracyclines, and ilomastat block Bacillus anthracis lethal factor activity in viable cells.
Kocer SS; Walker SG; Zerler B; Golub LM; Simon SR
Infect Immun; 2005 Nov; 73(11):7548-57. PubMed ID: 16239558
[TBL] [Abstract][Full Text] [Related]
35. Anti-proliferative role of recombinant lethal toxin of Bacillus anthracis on primary mammary ductal carcinoma cells revealing its therapeutic potential.
Khandia R; Pattnaik B; Rajukumar K; Pateriya A; Bhatia S; Murugkar H; Prakash A; Pradhan HK; Dhama K; Munjal A; Joshi SK
Oncotarget; 2017 May; 8(22):35835-35847. PubMed ID: 28415766
[TBL] [Abstract][Full Text] [Related]
36. Molecular dynamics simulations of complexes between wild-type and mutant anthrax protective antigen variants and a model anthrax toxin receptor.
Stiles L; Nelson DJ
J Biomol Struct Dyn; 2005 Apr; 22(5):503-19. PubMed ID: 15702923
[TBL] [Abstract][Full Text] [Related]
37. [Anthrax toxins].
Brossier F; Guidi-Rontani C; Mock M
C R Seances Soc Biol Fil; 1998; 192(3):437-44. PubMed ID: 9759382
[TBL] [Abstract][Full Text] [Related]
38. Anthrax toxin complexes: heptameric protective antigen can bind lethal factor and edema factor simultaneously.
Pimental RA; Christensen KA; Krantz BA; Collier RJ
Biochem Biophys Res Commun; 2004 Sep; 322(1):258-62. PubMed ID: 15313199
[TBL] [Abstract][Full Text] [Related]
39. Lethal factor of anthrax toxin binds monomeric form of protective antigen.
Chvyrkova I; Zhang XC; Terzyan S
Biochem Biophys Res Commun; 2007 Aug; 360(3):690-5. PubMed ID: 17617379
[TBL] [Abstract][Full Text] [Related]
40. Imaging specific cell surface protease activity in living cells using reengineered bacterial cytotoxins.
Hobson JP; Liu S; Leppla SH; Bugge TH
Methods Mol Biol; 2009; 539():115-29. PubMed ID: 19377967
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
